Co-Authors
This is a "connection" page, showing publications co-authored by Changgui Li and Shibao Yao.
Connection Strength
0.059
-
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial. Vaccine. 2021 05 12; 39(20):2746-2754.
Score: 0.059
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.